Suppr超能文献

将ABCC1转运蛋白核苷酸结合域作为多药耐药癌症治疗靶点的虚拟筛选

Virtual screening of ABCC1 transporter nucleotidebinding domains as a therapeutic target in multidrug resistant cancer.

作者信息

Rungsardthong Kanin, Mares-Sámano Sergio, Penny Jeffrey

机构信息

University of Manchester, School of Pharmacy & Pharmaceutical Sciences, Stopford Building, M13 9PT, UK.

出版信息

Bioinformation. 2012;8(19):907-11. doi: 10.6026/97320630008907. Epub 2012 Oct 1.

Abstract

UNLABELLED

ABCC1 is a member of the ATP-binding Cassette super family of transporters, actively effluxes xenobiotics from cells. Clinically, ABCC1 expression is linked to cancer multidrug resistance. Substrate efflux is energised by ATP binding and hydrolysis at the nucleotide-binding domains (NBDs) and inhibition of these events may help combat drug resistance. The aim of this study is to identify potential inhibitors of ABCC1 through virtual screening of National Cancer Institute (NCI) compounds. A threedimensional model of ABCC1 NBD2 was generated using MODELLER whilst the X-ray crystal structure of ABCC1 NBD1 was retrieved from the Protein Data Bank. A pharmacophore hypothesis was generated based on flavonoids known to bind at the NBDs using PHASE, and used to screen the NCI database. GLIDE was employed in molecular docking studies for all hit compounds identified by pharmacophore screening. The best potential inhibitors were identified as compounds possessing predicted binding affinities greater than ATP. Approximately 5% (13/265) of the hit compounds possessed lower docking scores than ATP in ABCC1 NBD1 (NSC93033, NSC662377, NSC319661, NSC333748, NSC683893, NSC226639, NSC94231, NSC55979, NSC169121, NSC166574, NSC73380, NSC127738, NSC115534), whereas approximately 7% (7/104) of docked NCI compounds were predicted to possess lower docking scores than ATP in ABCC1 NBD2 (NSC91789, NSC529483, NSC211168, NSC318214, NSC116519, NSC372332, NSC526974). Analyses of docking orientations revealed P-loop residues of each NBD and the aromatic amino acids Trp653 (NBD1) and Tyr1302 (NBD2) were key in interacting with high-affinity compounds. On the basis of docked orientation and docking score the compounds identified may be potential inhibitors of ABCC1 and require further pharmacological analysis.

ABBREVIATIONS

ABC - ATP-binding cassette, DHS - dehydrosilybin, MDR - multidrug resistance, NBD - nucleotide-binding domain, PDB - protein data bank.

摘要

未标记

ABCC1是ATP结合盒转运蛋白超家族的成员,可将外源性物质从细胞中主动外排。在临床上,ABCC1的表达与癌症多药耐药性相关。底物外排由核苷酸结合域(NBD)处的ATP结合和水解提供能量,抑制这些过程可能有助于对抗耐药性。本研究的目的是通过对美国国立癌症研究所(NCI)化合物进行虚拟筛选来鉴定ABCC1的潜在抑制剂。使用MODELLER生成ABCC1 NBD2的三维模型,同时从蛋白质数据库中检索ABCC1 NBD1的X射线晶体结构。基于已知在NBD处结合的黄酮类化合物,使用PHASE生成药效团假设,并用于筛选NCI数据库。对药效团筛选鉴定出的所有命中化合物进行分子对接研究时采用了GLIDE。最佳潜在抑制剂被鉴定为预测结合亲和力大于ATP的化合物。在ABCC1 NBD1中,约5%(13/265)的命中化合物对接分数低于ATP(NSC93033、NSC662377、NSC319661、NSC333748、NSC683893、NSC226639、NSC94231、NSC55979、NSC169121、NSC166574、NSC73380、NSC127738、NSC115534),而在ABCC1 NBD2中,约7%(7/104)对接的NCI化合物预测对接分数低于ATP(NSC91789、NSC529483、NSC211168、NSC318214、NSC116519、NSC372332、NSC526974)。对接方向分析表明,每个NBD的P环残基以及芳香族氨基酸Trp653(NBD1)和Tyr1302(NBD2)在与高亲和力化合物相互作用中起关键作用。基于对接方向和对接分数,鉴定出的化合物可能是ABCC1的潜在抑制剂,需要进一步的药理学分析。

缩写

ABC - ATP结合盒,DHS - 脱氢水飞蓟宾,MDR - 多药耐药性,NBD - 核苷酸结合域,PDB - 蛋白质数据库

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac6c/3488831/cd9b1c6864aa/97320630008907F1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验